Drug combination may become new standard treatment for advanced kidney cancer

(Dana-Farber Cancer Institute) A combination of two drugs -- one of them an immunotherapy agent -- could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

Source: EurekAlert! - Medicine and Health - February 16, 2019 Category: International Medicine & Public Health Source Type: news